Pfizer Hit With $1.3B Fine For Bextra Marketing

Law360, New York (October 16, 2009, 7:15 PM EDT) -- A federal court has levied a record $1.3 billion criminal fine — the largest ever imposed in the U.S. — against Pfizer Inc. subsidiary Pharmacia & Upjohn Co. Inc. for fraudulently misbranding its anti-inflammatory drug Bextra.

Judge Douglas Woodlock of the U.S. District Court for the District of Massachusetts sentenced Pharmacia to pay a criminal fine of $1.195 billion and a criminal forfeiture of $105 million, a total of $1.3 billion, at a hearing Friday.

The U.S. Attorney’s Office of Massachusetts, which prosecuted the case on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.